These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22623694)

  • 1. Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings.
    Fukukura Y; Takumi K; Kamimura K; Shindo T; Kumagae Y; Tateyama A; Nakajo M
    Radiology; 2012 Jun; 263(3):732-40. PubMed ID: 22623694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative detection of small pancreatic carcinoma: value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level.
    Park MJ; Kim YK; Choi SY; Rhim H; Lee WJ; Choi D
    Radiology; 2014 Nov; 273(2):433-43. PubMed ID: 24991989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience.
    Zhang J; Tehrani YM; Wang L; Ishill NM; Schwartz LH; Hricak H
    Radiology; 2008 May; 247(2):458-64. PubMed ID: 18430878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.
    Kang KM; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Feb; 270(2):444-53. PubMed ID: 24126370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
    Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
    Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MR imaging of the pancreas: optimizing b-value for visualization of pancreatic adenocarcinoma.
    Fukukura Y; Shindo T; Hakamada H; Takumi K; Umanodan T; Nakajo M; Kamimura K; Umanodan A; Ideue J; Yoshiura T
    Eur Radiol; 2016 Oct; 26(10):3419-27. PubMed ID: 26738506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging.
    Fukukura Y; Kumagae Y; Hakamada H; Shindo T; Takumi K; Kamimura K; Nakajo M; Umanodan A; Yoshiura T
    Eur J Radiol; 2017 Oct; 95():39-45. PubMed ID: 28987696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
    Matoba M; Tonami H; Kondou T; Yokota H; Higashi K; Toga H; Sakuma T
    Radiology; 2007 May; 243(2):570-7. PubMed ID: 17400757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T.
    Bogner W; Pinker K; Zaric O; Baltzer P; Minarikova L; Porter D; Bago-Horvath Z; Dubsky P; Helbich TH; Trattnig S; Gruber S
    Radiology; 2015 Jan; 274(1):74-84. PubMed ID: 25341078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging.
    Yamashita Y; Namimoto T; Mitsuzaki K; Urata J; Tsuchigame T; Takahashi M; Ogawa M
    Radiology; 1998 Sep; 208(3):605-9. PubMed ID: 9722835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
    Kim JH; Park SH; Yu ES; Kim MH; Kim J; Byun JH; Lee SS; Hwang HJ; Hwang JY; Lee SS; Lee MG
    Radiology; 2010 Oct; 257(1):87-96. PubMed ID: 20697118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
    Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
    Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
    Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
    Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of focal pancreatic lesions using normalized apparent diffusion coefficient at 1.5-Tesla: preliminary experience.
    Barral M; Sebbag-Sfez D; Hoeffel C; Chaput U; Dohan A; Eveno C; Boudiaf M; Soyer P
    Diagn Interv Imaging; 2013 Jun; 94(6):619-27. PubMed ID: 23545001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion weighted MR imaging of pancreatic islet cell tumors.
    Bakir B; Salmaslioğlu A; Poyanli A; Rozanes I; Acunas B
    Eur J Radiol; 2010 Apr; 74(1):214-20. PubMed ID: 19264435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma.
    Fukukura Y; Takumi K; Higashi M; Shinchi H; Kamimura K; Yoneyama T; Tateyama A
    Eur J Radiol; 2014 Apr; 83(4):612-9. PubMed ID: 24418286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Diagnostic Performances of Three Techniques of ROI Placement for ADC Measurements in Pancreatic Adenocarcinoma.
    Liu L; Ma C; Li J; Wang L; Chen LG; Zhang Y; Chen SY; Lu JP
    Acad Radiol; 2015 Nov; 22(11):1385-92. PubMed ID: 26292914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.